MRD in AML: The Role of New Techniques

In the context of precision medicine, assessment of minimal residual disease (MRD) has been used in acute myeloid leukemia (AML) to direct individual treatment programs, including allogeneic stem cell transplantation in patients at high-risk of relapse. One of the limits of this approach has been in...

Full description

Bibliographic Details
Main Authors: Maria Teresa Voso, Tiziana Ottone, Serena Lavorgna, Adriano Venditti, Luca Maurillo, Francesco Lo-Coco, Francesco Buccisano
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-07-01
Series:Frontiers in Oncology
Subjects:
NGS
MRD
AML
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.00655/full